Thinking refractively in terms of ocular surgery As optometrists, we think about refractive endpoints for glasses and contacts daily but rarely think about it in terms of ocular surgery. Having been fortunate to work with surgeons whose goal was to...
The International Workshop in Meibomian Gland Dysfunction (MGD) The international workshop in Meibomian Gland Dysfunction (MGD) gave us the blueprint for success for diagnosis and management for MGD.  It has been defined as:  “a chronic, diffuse abnormality of the meibomian...
Prevention is possible with today's technology It's 2017 and the prevention of eye disease is absolutely possible with early detection through technology. Medicine is advancing faster than we can keep up with it, but there is one thing that holds...
An OD is looking for any recommendations beyond what he has tried alerady with his patient with a diagnosis of exposure keratopathy. Read & Comment on ODs on Facebook
A busy OD shows photos of the interesting and complex patient's they see in all in a day's work! Read & Comment on ODs on Facebook
Keratoconus is more common than you think Keratoconus is an asymmetric, bilateral, frequently progressive corneal disease that is more common than you think. Back in the mid-1980’s studies were developed to roughly and likely inaccurately estimate the incidence and prevalence...
A 14-year-old patient is seen in the ER and the doctor prescribes gentamycin for an unfortunate outcome. When the patient comes in to see the OD, the results of the treatment are shocking and sad. Read & Comment on ODs on Facebook
An OD makes an unfortunate discovery of critters under the lenses of a patient who tries hybrid contacts. Read & Comment on ODs on Facebook  
Clinical query: How would you treat recurrent corneal erosion in a patient who is uncomfortable with debridement or stromal puncture? Read & Comment on ODs on Facebook  
Find out what your colleagues are saying about the big news, with links to coverage and videos.  FDA approves Avedro's Photrexa® Viscous, Photrexa® and KXL® System for use in corneal cross-linking. The first and only FDA approved therapeutic treatment...

Send this to a friend